This could be another reason Starpharma wants to manufacture its BV formulation in-house.....to maintain quantity control.....
https://www.biopharmadive.com/news/fda-gottlieb-trump-regulation-guidance-manufacturing/517589/
Add to My Watchlist
What is My Watchlist?